Universitätsklinikum Schleswig-Holstein (UKSH)

Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice (2014) Bergmann L, Beck J, Bothe K, Brinkmann OA, Buse S, Goebell P, Gruenwald V, et al. Journal article Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (2014) Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, et al. Journal article Combining EEG and MEG for the reconstruction of epileptic activity using a calibrated realistic volume conductor model (2014) Aydin U, Vorwerk J, Kuepper P, Heers M, Kugel H, Galka A, Hamid L, et al. Journal article Differentiated antiplatelet therapy for acute coronary syndromes (2014) Schaefer A, Arntz HR, Boudriot E, Garlichs C, Hoffmann S, Ince H, Klingenheben T, et al. Journal article Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia (2014) Meissner B, Bartram T, Eckert C, Trka J, Panzer-Grümayer R, Hermanova I, Ellinghaus E, et al. Journal article Skin irritability to sodium lauryl sulfate is associated with increased positive patch test reactions (2014) Schwitulla J, Brasch J, Löffler H, Schnuch A, Geier J, Uter W Journal article Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutions (2014) Eigentler TK, Schlaak M, Hassel JC, Loquai C, Stoffels I, Gutzmer R, Paetzold S, et al. Journal article Microsurgical training in Germany - results of a survey among trainers and trainees (2014) Kolbenschlag J, Gehl B, Daigeler A, Kremer T, Hirche C, Vogt PM, Horch RE, et al. Journal article Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2014) Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, et al. Journal article PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014) Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al. Journal article